Ovarian tumor cell sensitivity then resistance - to chemotherapy linked to genetic abnormality

BOSTONResearchers at Dana-Farber Cancer Institute and a team of international collaborators have identified a genetic abnormality that makes some ovarian tumor cells initially sensitive to a common chemotherapy agent, cisplatin, and then resistant to the drug over time.

Published in the May issue of Nature Medicine, the study challenges conventional thinking about how cancer cells are able to "outsmart" therapies that at first are effective against them.

"It has been thought that as normal cells evolve into cancerous ones, they acquire more and more genetic damage to the point where they gain the ability to withstand drugs that once killed them," says the study's senior author, Alan D'Andrea, MD, of Dana-Farber and Children's Hospital Boston. "While that may indeed take place, our study points to another possibility: that cancer cells can, in effect, 'go backward,' switching some genes to a normal state so they essentially disguise themselves from common therapeutic agents."

The finding represents both a hurdle to the development of new anti-cancer drugs and, paradoxically, a crucial step toward the discovery of such drugs. Scientists working on drug development now know that they are chasing more of a moving target than they may have realized. They also have a better sense, however, of how to counter these cellular shifts.

The new study stems from D'Andrea's research in Fanconi anemia, an inherited condition that places children at risk for bone marrow failure early in life and various forms of cancer as they get older. The disease is caused by a defect, or mutation, in any of seven genes that act as a tag-team to repair damaged DNA. Over the last few years, D'Andrea and his colleagues found that this gene "pathway" leads directly to BRCA1 and BRCA2, two of the best known cancer genes in human cells. When either of the BRCA genes or any of those in the Fanconi pathway are mutated, the result can be breast cancer, ovarian cancer

Contact: Bill Schaller
Dana-Farber Cancer Institute

Page: 1 2 3

Related biology news :

1. Ovarian cancer sheds tumor suppression with loss of estrogen receptor
2. Ovarian cancer detected in blood samples
3. Ovarian stimulation in mice adversely affects embryo development and implantation
4. Study Suggests Vaccine Increases Survival In Ovarian And Breast Cancer Patients Following High-Dose Chemotherapy And Autologous Stem Cell Transplant
5. UI Researchers Find Possible Genetic Link Between The X Chromosome And Ovarian Cancer
6. Gene Knockout Prolongs Ovarian Lifespan In Mice
7. Gene Once Thought To Program Ovarian Development Instead Found To Be Critical For Production Of Sperm
8. Cold Virus With P53 Gene Tested To Combat Ovarian Cancer
9. Multi-Center Study Provides Guidelines For Genetic Testing In Women With Breast Cancer: BRCA Abnormalities Multiply Risk Of Ovarian Cancer
10. Researchers identify protein promoting vascular tumor growth
11. Gene expression in liver tumors and patient prognosis

Post Your Comments:

(Date:4/27/2019)... ... April 26, 2019 , ... ... Assessment Report: The Laboratory Analytical & Life Science Instrumentation Industry ," provides ... that include chromatography, life science instrumentation, mass spectrometry, molecular spectroscopy, atomic spectroscopy, ...
(Date:4/25/2019)... ROCHELLE, Va. (PRWEB) , ... April 24, 2019 , ... ... a biostatistician with more than 20 years of experience in the development of drug ... an Expert Consultant. , Prior to joining NDA Partners, Dr. Maddala served as ...
(Date:4/18/2019)... Conn. and WALNUT CREEK, Calif. (PRWEB) , ... ... ... cost management solution for the healthcare industry, today announced the launch of mSource® ... language processing to extract deep knowledge of Medpricer customers’ supplier contracts, truly optimizing ...
Breaking Biology News(10 mins):
(Date:5/2/2019)... ... , ... Boston Robotic Hair Restoration announces the most advanced ... of painful hair transplant procedures. Boston Robotic Hair Restoration offers the newest, state-of-the-art ... solution to offer a minimally invasive procedure. With the ARTAS® iX robotics, patients ...
(Date:4/16/2019)... ... 16, 2019 , ... Fulcrum Biometrics , a leading ... South Pacific (BSP), the largest regionally owned bank in the South Pacific, selected ... to deliver a fingerprint-based Know Your Customer (KYC) banking solution that is being ...
(Date:4/9/2019)... Calif. (PRWEB) , ... April 09, 2019 , ... ... services firm focused on increasing the capacity of life sciences organizations to accelerate ... Cloud Assurance platform in the past 12 months. , USDM’s ...
(Date:4/8/2019)... ... April 09, 2019 , ... To ... research center Chan Zuckerberg Biohub (CZ Biohub) has chosen Geneious Biologics to help ... part of CZ Biohub’s efforts to establish new approaches to inform the discovery ...
Breaking Biology Technology:
Cached News: